{
    "paper_id": "PMC7234827",
    "metadata": {
        "title": "SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy",
        "authors": [
            {
                "first": "Berthold",
                "middle": [],
                "last": "Bein",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Martin",
                "middle": [],
                "last": "Bachmann",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Susanne",
                "middle": [],
                "last": "Huggett",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Petra",
                "middle": [],
                "last": "Wegermann",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\nThe new coronavirus, known as SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2), has caused a global pandemic within a short period of time. The clinical presentation, i.e., the disease itself, has been given the name COVID-19 (corona virus disease 2019). Since the initial period of transmission of infections, the number of infections reported in the People\u02bcs Republic of China and in numerous European countries has risen exponentially\n1\nand significantly exceeded the capacity of healthcare systems in certain countries such as Italy. Physicians and nursing staff are therefore in urgent need of information about efficient ways of diagnosing the disease and evidence-based treatment.\n",
            "cite_spans": [
                {
                    "start": 451,
                    "end": 452,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "\nIt is currently assumed that SARS-CoV-2 was present in an animal reservoir (the market for seafood and reptiles in Wuhan, People\u02bcs Republic of China) from where it passed to human hosts at the beginning of December 2019\n2\n. The original reservoir species is still unknown, but bats are considered the most likely source\n3\n. With Wuhan as the starting point, the virus spread across all of mainland China, with a significant concentration of cases occurring in the province of Hubei\n4\n.\n",
            "cite_spans": [
                {
                    "start": 221,
                    "end": 222,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 321,
                    "end": 322,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 483,
                    "end": 484,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nInitially, the number of infections in all affected countries increased exponentially, although the curve has since flattened following drastic measures taken by some countries to avoid social contacts (People\u02bcs Republic of China, Taiwan, Singapore)\n5\n. The characteristic exponential infection curve is due to SARS-CoV-2 being highly contagious. Based on a meta-analysis of 12 studies published until 7 February 2020, the mean basic reproduction number for SARS-CoV-2 is currently 3.28 infections per infected individual, a considerably higher number than that of SARS.\n",
            "cite_spans": [
                {
                    "start": 251,
                    "end": 252,
                    "mention": "5",
                    "ref_id": "BIBREF44"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nData from China suggested, that every infected individual infects an average of 3.28 other people\n6\n.\n",
            "cite_spans": [
                {
                    "start": 99,
                    "end": 100,
                    "mention": "6",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nAccording to current calculations, the case fatality rate (= the number of infected persons who die of the infection; lethality) of SARS-CoV-2 is just 1.4%, although the risk of developing symptomatic infection increases with age (approx. 4% per year for adults between the ages of 30 \u2013 60 years)\n7\n. Patients over the age of 59 years have a 5-fold higher risk of dying from COVID-19. Children are often not affected or only to a minor extent, but they can pass on the infection. It is currently not expected that large numbers of children will be seriously affected\n8\n.\n",
            "cite_spans": [
                {
                    "start": 298,
                    "end": 299,
                    "mention": "7",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 568,
                    "end": 569,
                    "mention": "8",
                    "ref_id": "BIBREF47"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nThe average incubation period is about 5 \u2013 6 days (range: 0 \u2013 14 days). However, the virus is still detectable in infected persons up to 30 days from onset of illness, which makes it more difficult to classify asymptomatic patients as cured even if they appear to have recovered from the infection\n9\n.\n",
            "cite_spans": [
                {
                    "start": 299,
                    "end": 300,
                    "mention": "9",
                    "ref_id": "BIBREF48"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nThere is currently insufficient evidence to be able to say whether persons who had the disease develop immunity and how long this immunity persists\n10\n. Data from animal studies suggest that, as with other viral diseases, infected individuals do develop immunity which subsequently prevents clinically apparent reinfection\n11\n.\n",
            "cite_spans": [
                {
                    "start": 149,
                    "end": 151,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 324,
                    "end": 326,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "\nCOVID-19 is primarily an infection of the upper and lower respiratory tract. The efficient proliferation of the virus within the nasopharyngeal cavity is considered one of the reasons for the high contagiousness of the virus\n12\n. Otherwise, the clinical characteristics of SARS-CoV-2 resemble those of other viral diseases which affect the lungs: fever, cough, fatigue.\n",
            "cite_spans": [
                {
                    "start": 226,
                    "end": 228,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Clinical Characteristics",
            "ref_spans": []
        },
        {
            "text": "\nAccording to data from the People\u02bcs Republic of China, more than 80% of affected patients are asymptomatic or present with only mild symptoms, around 15% develop more serious general symptoms including pneumonia, and around 5% of patients become critically ill and develop sepsis, septic shock or multi-organ failure\n13\n, \n14\n, \n15\n, \n16\n, \n17\n, \n18\n(\nTable 1\n). The lethality is between 1 \u2013 2%. Men are affected significantly more often than women\n16\n, \n23\n. The figures may vary, depending on the intensity and time of testing. This appears to be the case in Italy.\n",
            "cite_spans": [
                {
                    "start": 318,
                    "end": 320,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 324,
                    "end": 326,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 330,
                    "end": 332,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 336,
                    "end": 338,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 342,
                    "end": 344,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 348,
                    "end": 350,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 450,
                    "end": 452,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 456,
                    "end": 458,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Clinical Characteristics",
            "ref_spans": [
                {
                    "start": 353,
                    "end": 360,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "\nCritically ill patients present with the classic features of ARDS including hyaline membrane formation, consolidated areas in the lungs and atelectasis\n19\n. Images of the thorax obtained with computed tomography show ground-glass opacity in more than 50% of cases and bilateral shadows\n16\n; bilateral shadowing was also found in > 50% of cases with conventional X-ray imaging\n20\n.\n",
            "cite_spans": [
                {
                    "start": 153,
                    "end": 155,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 287,
                    "end": 289,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 377,
                    "end": 379,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Clinical Characteristics",
            "ref_spans": []
        },
        {
            "text": "\nOn admission to hospital, more than 80% of patients were found to have lymphocytopenia; laboratory tests in a cohort of 173 patients from Wuhan with severe disease showed elevated CRP (\u2265 10 mg/l, 81.5%), LDH (\u2265 250 U/l, 58.1%) and D-dimer (\u2265 0.5 mg/l, 59.8%) levels in a majority of patients, while only 13.7% of patients had elevated procalcitonin levels of more than \u2265 0.5 ng/l\n16\n. Elevated D-dimer and serum ferritin levels have also been reported in other cohorts\n21\n, \n22\n.\n",
            "cite_spans": [
                {
                    "start": 381,
                    "end": 383,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 470,
                    "end": 472,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 476,
                    "end": 478,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Clinical Characteristics",
            "ref_spans": []
        },
        {
            "text": "In general, it appears that older men with comorbidities are more likely to fall ill and more likely to die.",
            "cite_spans": [],
            "section": "Clinical Characteristics",
            "ref_spans": []
        },
        {
            "text": "\nAround half of patients with COVID-19 have chronic comorbidities; the majority have cardiovascular or cerebrovascular comorbidities or diabetes mellitus\n23\n. Some patients with severe course of disease had coinfections with bacteria and fungi. Examination of cultures has identified\nAcinetobacter baumannii, Klebsiella pneumoniae, Aspergillus flavus, Candida glabrata\nand\nCandida albicans\namong others\n23\n.\n",
            "cite_spans": [
                {
                    "start": 154,
                    "end": 156,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 403,
                    "end": 405,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Clinical Characteristics",
            "ref_spans": []
        },
        {
            "text": "In cases suspicious for infection with SARS-CoV-2, the Robert Koch Institute (RKI) recommends obtaining parallel samples from the upper and lower respiratory tract, depending on the clinical situation. It is important to use swabs suitable for detecting the virus (virus swabs with an appropriate transport medium or, if necessary, dry swabs moistened with a small amount of NaCl solution; no agar swabs).",
            "cite_spans": [],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nThe material should be examined with RT-PCR for the presence of viral RNA\n24\n. If the material needs to be preserved for longer periods, it must be stored at a temperature of 4 \u00b0C.\n",
            "cite_spans": [
                {
                    "start": 75,
                    "end": 77,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nAccording to the recommendations of the RKI (\nwww.rki.de/covid-19-falldefinition\n; as per: 28.03.2020), testing should focus on symptomatic persons and individuals suspected of having the virus based on a differential diagnosis.\n",
            "cite_spans": [],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nA clinical suspicion of infection is based on an individual\u02bcs previous history, symptoms or findings consistent with COVID-19 disease, and whether a diagnosis for a different disease exists which could adequately explain the presenting symptoms and clinical picture\n25\n.\n",
            "cite_spans": [
                {
                    "start": 267,
                    "end": 269,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "In practice, the recurrent issue for medical staff is which contacts should lead to testing.",
            "cite_spans": [],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nA category 1 contact person is defined a person who had face-to-face contact for a cumulative period of at least 15 minutes with a known COVID-19 patient, e.g. during a conversation\n25\n. Persons who had this type of contact should initially be sent home to self-isolate (quarantine) for 14 days. For medical staff, this category has been subdivided further into category 1a and 1b contact persons.\n",
            "cite_spans": [
                {
                    "start": 183,
                    "end": 185,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nA category 1a contact is a person with high-risk exposure, e.g. someone who had unprotected exposure to secretions and aerosols from COVID-19 patients (intubation and extubation of the patient, bronchoscopy, aspiration, nebulisation, manual ventilation prior to endotracheal anaesthesia, proning the patient, noninvasive ventilation (NIV), tracheotomy and cardiopulmonary resuscitation)\n26\n. This group of people should usually be required to quarantine themselves at home for a period of 14 days. As medical staff are a very limited resource, in view of the shortage of relevant staff, the RKI has recommended a shorter isolation period of 7 days for this group.\n",
            "cite_spans": [
                {
                    "start": 388,
                    "end": 390,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "Persons classified as contact category 1b had contact with a confirmed COVID-19 case in the context of delivering care or undertaking a medical examination (> 15 min, \u2264 2 m distance) without personal protective equipment but also without carrying out a high-risk procedure. Because of the shortage of staff, this group of persons may continue working but should use a surgical mask to cover their mouth and nose for a period of 14 days.",
            "cite_spans": [],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nNo special precautions are required for category 3 contact persons; this category covers medical staff who were in the same room as a confirmed COVID-19 case and were not wearing adequate personal protective equipment but were never closer than 2 metres, did not come into direct contact with secretions or excretions of the patient and were not exposed to aerosols as well as medical staff who were closer than 2 m to the patient but were wearing adequate personal protective equipment throughout the entire contact period\n26\n.\n",
            "cite_spans": [
                {
                    "start": 525,
                    "end": 527,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "The overview below summarises the contact categories and appropriate response for each category.",
            "cite_spans": [],
            "section": "Diagnosis",
            "ref_spans": []
        },
        {
            "text": "\nIn addition to strict observance of the rules of basic hygiene, it is critically important to ensure that staff are adequately provided with personal protective equipment. Because the disease is highly contagious, use of a FFP2/FFP3 (face filtering piece) respirator mask is recommended for all aerosol-generating procedures performed when caring for patients. Staff must additionally wear protective goggles and a waterproof apron or gown\n28\n.\n",
            "cite_spans": [
                {
                    "start": 441,
                    "end": 443,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Hygiene Measures",
            "ref_spans": []
        },
        {
            "text": "\nClass 2 and 3 FFP masks are characterised by a very low levels of overall leakage, which is why they offer good protection against aerosols (droplet infection); however, working while wearing FFP2/FFP3 respirator masks is only possible for limited periods of time because of the high breathing resistance\n29\n.\n",
            "cite_spans": [
                {
                    "start": 306,
                    "end": 308,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Hygiene Measures",
            "ref_spans": []
        },
        {
            "text": "\nAs it is expected that supplies of FFP2/FFP3 respirator masks will be insufficient during the pandemic, it is necessary to also think about alternative approaches in an emergency. In its recently published recommendations on the treatment of patients with COVID-19, the Surviving Sepsis Campaign (SSC) cited a current meta-analysis which did not find special respiratory masks (analogous to our FFP2/FFP3 masks) to be superior to conventional surgical masks with regard to preventing the infection from spreading to healthcare staff who treated infectious patients\n30\n. A randomised study on the treatment of patients which included a number of patients infected with the coronavirus also reported that surgical masks were noninferior to N95 respirator masks\n31\n. This means that, in exceptional situations, providing patients\nand\nhealthcare staff with surgical masks could be a useful means of reducing the risk of infection for medical staff, at least when treating spontaneously breathing patients.\n",
            "cite_spans": [
                {
                    "start": 566,
                    "end": 568,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 760,
                    "end": 762,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Hygiene Measures",
            "ref_spans": []
        },
        {
            "text": "\nHowever, during all aerosol-generating procedures, it is absolutely essential that medical staff wear a FFP2 mask at the very least, or better still a FFP3 mask (see above) for their own protection. The German Society for Pneumology and Respiratory Medicine recently published detailed recommendations\n32\n. To reduce the use of FFP2/FFP3 masks, it is recommended that medical staff wear personal protective equipment (PPE) during as many of their encounters with patients as possible. When treating patients with the virus who are on the same ward, several patients can be treated while wearing the same PPE. Between contacts with patients, the FFP mask can be placed between 2 low-microbe disposable cardboard kidney dishes if it is possible to prevent the inside of the mask from being contaminated.\n",
            "cite_spans": [
                {
                    "start": 303,
                    "end": 305,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Hygiene Measures",
            "ref_spans": []
        },
        {
            "text": "To ensure that sufficient PPE is available for all medical staff despite the increased demand during the pandemic, tests are currently being carried out to see whether it would be possible to re-use used FFPS masks using suitable reprocessing methods. Before the reprocessed masks are released for use, it will be necessary to test whether the masks continue to fulfil their protective function after reprocessing.",
            "cite_spans": [],
            "section": "Hygiene Measures",
            "ref_spans": []
        },
        {
            "text": "\nOutside best standard care, there is also a huge interest in new and experimental treatment procedures, although there are currently no data available for the overwhelming majority of new procedures. A very recently published study on the use of a combination of lopinavir and ritonavir was unable to show any survival benefits for COVID-19 patients\n39\n.\n",
            "cite_spans": [
                {
                    "start": 351,
                    "end": 353,
                    "mention": "39",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nRemdesivir (pharmaceutical company: Gilead Sciences, Inc.) is another effective antiviral agent which was originally developed to treat infections associated with the Ebola virus. Remdesivir is effective to treat a wide range of different viruses, including filoviruses, paramyxoviruses, pneumo-viruses and pathogenic coronaviruses\n40\n. In cell cultures inoculated with Middle East respiratory syndrome coronaviruses, remdesivir was found to be superior to a combination of lopinavir/ritonavir\n30\n. The first data from Chinese patients are expected in early April. However, the substance is currently not available in Germany outside of controlled trials.\n",
            "cite_spans": [
                {
                    "start": 333,
                    "end": 335,
                    "mention": "40",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 495,
                    "end": 497,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nEarly on, the suggestion was made that chloroquine could be a potentially effective antiviral drug; however, positive results in cell cultures and animal experiments could not be replicated or confirmed in clinical practice\n41\n. A recent Letter to the Editor\n42\nreported positive effects in 100 patients in a Chinese multicentre study. In the group which received the drug, it was found to prevent exacerbation of pneumonia, improve X-ray findings and shorten the overall course of disease. No relevant side effects were noted. There are currently no peer-reviewed publications on its use in this context; a recent systematic review into the use of chloroquine to treat COVID-19 disease recommended that chloroquine should only be administered in accordance with the Monitored Emergency Use of Unregistered Interventions (MEURI) protocol\n43\n.\n",
            "cite_spans": [
                {
                    "start": 225,
                    "end": 227,
                    "mention": "41",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 260,
                    "end": 262,
                    "mention": "42",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 839,
                    "end": 841,
                    "mention": "43",
                    "ref_id": "BIBREF37"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nBased on the available evidence, it is currently not possible to recommend any of these therapies. In each case, an individual risk-benefit assessment is necessary prior to initiating the off-label use of particular substances, as serious side effects have been reported\n44\n.\n",
            "cite_spans": [
                {
                    "start": 272,
                    "end": 274,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nThere is also considerable interest in the use of extracorporeal membrane oxygenation (ECMO) as an emergency therapy\n45\n. Veno-venous ECMO (vv-ECMO) is already an established procedure to treat refractory respiratory failure and appears to be associated with a survival benefit in a subgroup of patients\n46\n, \n47\n. There is general agreement that this therapy should only be carried out in experienced centres. As with other medical procedures, a minimum of 20 veno-venous ECMO runs per year is considered the minimum entry criterion\n20\n.\n",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 120,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 305,
                    "end": 307,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 311,
                    "end": 313,
                    "mention": "47",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 535,
                    "end": 537,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nA small subgroup of COVID-19 patients experience a cytokine storm during infection, which is caused by an overwhelming and excessive release of proinflammatory cytokines (e.g. IL-2, IL-7, interferon-\u03b3, TNF-\u03b1)\n22\n. Serum ferritin and IL-6 levels were found to be significantly elevated in samples obtained from deceased individuals from this subgroup of patients\n48\n. This is the rationale behind specific anti-inflammatory treatments, for example, the administration of interferon \u03b2-1b, the IL-1 blocker anakinra, the IL-6 receptor blocker tocilizumab or corticosteroids. There are no evidence-based data for any of the therapies mentioned here; analogously to the recommendations on the treatment of septic shock, corticosteroids may be considered as a hydrocortisone therapy (200 mg/24 h) in patients with high vasopressor doses.\n",
            "cite_spans": [
                {
                    "start": 210,
                    "end": 212,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 363,
                    "end": 365,
                    "mention": "48",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "\nImproved outcomes were reported in a case series of patients with septic shock and high cytokine concentrations (e.g. an IL-6 of \u2265 1000 pg/ml) following the use of a cytokine filter (Cytosorbents, Berlin, Germany)\n49\n. This requires an extracorporeal circulation (hemofiltration and/or ECMO) in which the filter can be incorporated. Cytokine removal could be an interesting treatment option for patients who meet the criteria. Antibiotic dosages may need to be adjusted accordingly.\n",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 217,
                    "mention": "49",
                    "ref_id": "BIBREF43"
                }
            ],
            "section": "Experimental procedures ::: Treatment",
            "ref_spans": []
        },
        {
            "text": "This is a translation of \u201cSARS CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy\u201d published in: An\u00e4sthesiol Intensivmed Notfallmed Schmerzther 2020; 55: 257 \u2013 265",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Abb.\u20091: \n Zusammenfassung der klinischen Handlungsempfehlungen f\u00fcr COVID-19-Patienten [Daten aus: Alhazzani W, Moller MH, Arabi YM et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (in press).\ndoi:10.1007/s00134-020-06022-5\n].\n",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Abb.\u20092: \n Therapiealgorithmus f\u00fcr Patienten mit akuter hypox\u00e4mischer respiratorischer Insuffizienz als Folge von COVID-19 [Daten aus: Alhazzani W, Moller MH, Arabi YM et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (in press).\ndoi:10.1007/s00134-020-06022-5\n].\n",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig.\u20091: \n Summary of clinical recommendations to treat COVID-19 patients [data from: Alhazzani W, Moller MH, Arabi YM et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (in press).\ndoi:10.1007/s00134-020-06022-5\n].\n",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Fig.\u20092: \n Treatment algorithm for patients with acute hypoxemic respiratory insufficiency caused by COVID-19 [data from: Alhazzani W, Moller MH, Arabi YM et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (in press).\ndoi:10.1007/s00134-020-06022-5\n].\n",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Healthcare Professionals: frequently asked questions and answers. CDC",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "SARS-CoV-2 Viral load in upper respiratory specimens of infected patients",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "1177-1179",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2213-2600(20)30079-5"
                ]
            }
        },
        "BIBREF5": {
            "title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "323",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "497-506",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Clinical characteristics of coronavirus disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF8": {
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "1054-1062",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "McGoogan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.2648"
                ]
            }
        },
        "BIBREF10": {
            "title": "Acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Brodie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Slutsky",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "JAMA",
            "volume": "319",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Rothan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Byrareddy",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Autoimmun",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.jaut.2020.102433"
                ]
            }
        },
        "BIBREF12": {
            "title": "S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz, 1. Aufl., Langversion. Stand 04.12.2017",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jamainternmed.2020.0994"
                ]
            }
        },
        "BIBREF14": {
            "title": "COVID-19: consider cytokine storm syndromes and immunosuppression",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mehta",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "McAuley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "1033-1034",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507-513",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "BEM"
                    ],
                    "last": "Reusken",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "K"
                    ],
                    "last": "Broberg",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Haagmans",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eurosurveillance",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.2807/1560-7917.ES.2020.25.6.2000082"
                ]
            }
        },
        "BIBREF17": {
            "title": "Coronavirus SARS-CoV-2 \u2013 Hinweise zur Testung von Patienten auf Infektion mit dem neuartigen Coronavirus SARS-CoV-2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Coronavirus SARS-CoV-2 \u2013 Optionen zum Management von Kontaktpersonen unter medizinischem Personal bei Personalmangel",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "COVID-19: protecting health-care workers",
            "authors": [],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Empfehlungen Krankenhaushygiene: Hygieneanforderungen respiratorisch \u00fcbertragbare Infektions-Erkrankungen",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Infektionspr\u00e4vention im Rahmen der Pflege und Behandlung von Patienten mit \u00fcbertragbaren Krankheiten",
            "authors": [],
            "year": 2015,
            "venue": "Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz",
            "volume": "58",
            "issn": "",
            "pages": "1151-1170",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "The proximal origin of SARS-CoV-2",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "G"
                    ],
                    "last": "Andersen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rambaut",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "I"
                    ],
                    "last": "Lipkin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41591-020-0820-9"
                ]
            }
        },
        "BIBREF23": {
            "title": "Compounds with therapeutic potential against novel respiratory 2019 coronavirus",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Martinez",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Antimicrob Agents Chemother",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.00399-20"
                ]
            }
        },
        "BIBREF24": {
            "title": "N95 Respirators vs. Medical Masks for Preventing Influenza Among Health Care Personnel",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Radonovich",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Simberkoff",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Bessesen",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA",
            "volume": "322",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Empfehlung",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Brodie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Slutsky",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "JAMA",
            "volume": "319",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Authors Intensive Care Medicine (ICM) and Critical Care Medicine (CCM)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Oczkowski",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Derde",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive Care Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00134-020-06022-5"
                ]
            }
        },
        "BIBREF28": {
            "title": "Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kluge",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Janssens",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Welte",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Med Klin Intensivmed Notfallmed",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00063-020-00674-3"
                ]
            }
        },
        "BIBREF29": {
            "title": "Extravascular lung water predicts progression to acute lung injury in patients with increased risk",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "LeTourneau",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pinney",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Phillips",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Crit Care Med",
            "volume": "40",
            "issn": "",
            "pages": "847-854",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Best practice & research clinical anaesthesiology: Advances in haemodynamic monitoring for the perioperative patient",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bein",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Renner",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Best Pract Res Clin Anaesthesiol",
            "volume": "33",
            "issn": "",
            "pages": "139-153",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "DAZ online. WHO r\u00e4t doch nicht von Ibuprofen ab: Ibuprofen und COVID-19: WHO rudert zur\u00fcck",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "M\u00fcller",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "A Trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001282"
                ]
            }
        },
        "BIBREF33": {
            "title": "Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Adhikari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "Y-J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Infect Dis Poverty",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Potential interventions for novel coronavirus in China: A systematic review",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "92",
            "issn": "",
            "pages": "479-490",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Of chloroquine and COVID-19",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Touret",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "de Lamballerie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Antiviral Res",
            "volume": "177",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Biosci Trends",
            "volume": "14",
            "issn": "",
            "pages": "72-73",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cortegiani",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ingoglia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ippolito",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Crit Care",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.jcrc.2020.03.005"
                ]
            }
        },
        "BIBREF38": {
            "title": "Treating COVID-19 \u2013 Off-label drug use, compassionate use, and randomized clinical trials during pandemics",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Kalil",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.4742"
                ]
            }
        },
        "BIBREF39": {
            "title": "Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ramanathan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Antognini",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Combes",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2213-2600(20)30121-1"
                ]
            }
        },
        "BIBREF40": {
            "title": "Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "J"
                    ],
                    "last": "Peek",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mugford",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tiruvoipati",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Lancet",
            "volume": "374",
            "issn": "",
            "pages": "1351-1363",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Combes",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hajage",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Capellier",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "N Engl J Med",
            "volume": "378",
            "issn": "",
            "pages": "1965-1975",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive Care Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00134-020-05991-x"
                ]
            }
        },
        "BIBREF43": {
            "title": "Hemoadsorption by CytoSorb in septic patients: a case series",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kogelmann",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Jarczak",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Scheller",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Crit Care",
            "volume": "21",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Response to COVID-19 in Taiwan",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "H"
                    ],
                    "last": "Brook",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.3151"
                ]
            }
        },
        "BIBREF45": {
            "title": "2019 Novel coronavirus: where we are and what we know",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Infection",
            "volume": "48",
            "issn": "",
            "pages": "155-163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bushman",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41591-020-0822-7"
                ]
            }
        },
        "BIBREF47": {
            "title": "COVID-19 in children: initial characterization of the pediatric disease",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cruz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeichner",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Pediatrics",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2020-0834"
                ]
            }
        },
        "BIBREF48": {
            "title": "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "McGoogan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.2648"
                ]
            }
        }
    }
}